Gilbert Haase
Direktor/Vorstandsmitglied bei Septimanie Export
Profil
Gilbert Haase is currently a Director at Septimanie Export, Mistral Investissements, and a Member-Supervisory Board at MAbgène SA. He was previously the Chairman at Société Financière du Languedoc-Roussillon SAS, a Non-Voting Director at MAXMAT SA, and a Director at Cogra 48 SA. From 1989 to 2013, he served as the President of Sofilaro SAS.
Mr. Haase received his undergraduate degree from ISARA-Lyon in 1975.
Aktive Positionen von Gilbert Haase
| Unternehmen | Position | Beginn |
|---|---|---|
| Septimanie Export | Direktor/Vorstandsmitglied | - |
| Mistral Investissements | Direktor/Vorstandsmitglied | - |
MAbgène SA
 MAbgène SA BiotechnologyHealth Technology MAbgène SA is a French company that produces monoclonal antibodies and recombinant proteins through cell culture. The company is based in Alès, France. The company has two CLD platforms available, including a CHO-S platform and their proprietary EMABling® platform. LFB Biotechnologies SASU is a subsidiary of LFB BIOMANUFACTURING, which is ultimately controlled by the Government of France. MAbgène was acquired by LFB Biotechnologies SASU on November 30, 2007 for $4.09 million. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gilbert Haase
| Unternehmen | Position | Ende |
|---|---|---|
Sofilaro SAS
 Sofilaro SAS Investment ManagersFinance Sofilaro Gestion SAS provides venture capital investments services. It offers consultancy services for management and business concerns. The company was founded in December 2002 and is headquartered in Lattes, France. | Präsident | 01.03.2013 |
MAXMAT SA
 MAXMAT SA Medical SpecialtiesHealth Technology MAXMAT SA develops and manufactures diagnostic and medical instruments. The company was founded on April 1, 1999 and is headquartered in Montpellier, France. | Direktor/Vorstandsmitglied | - |
Société Financière du Languedoc-Roussillon SAS
 Société Financière du Languedoc-Roussillon SAS Environmental ServicesIndustrial Services Société Financière du Languedoc-Roussillon SAS is a waste management company based in Montpellier, France. and has subsidiaries in France. The French company engages in the treatment and disposal of non-hazardous waste. | Vorsitzender | - |
| COGRA 48 | Direktor/Vorstandsmitglied | - |
Ausbildung von Gilbert Haase
| ISARA-Lyon | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COGRA 48 | Non-Energy Minerals |
| Private Unternehmen | 6 |
|---|---|
MAXMAT SA
MAXMAT SA Medical SpecialtiesHealth Technology MAXMAT SA develops and manufactures diagnostic and medical instruments. The company was founded on April 1, 1999 and is headquartered in Montpellier, France. | Health Technology |
Sofilaro SAS
Sofilaro SAS Investment ManagersFinance Sofilaro Gestion SAS provides venture capital investments services. It offers consultancy services for management and business concerns. The company was founded in December 2002 and is headquartered in Lattes, France. | Finance |
Société Financière du Languedoc-Roussillon SAS
Société Financière du Languedoc-Roussillon SAS Environmental ServicesIndustrial Services Société Financière du Languedoc-Roussillon SAS is a waste management company based in Montpellier, France. and has subsidiaries in France. The French company engages in the treatment and disposal of non-hazardous waste. | Industrial Services |
MAbgène SA
MAbgène SA BiotechnologyHealth Technology MAbgène SA is a French company that produces monoclonal antibodies and recombinant proteins through cell culture. The company is based in Alès, France. The company has two CLD platforms available, including a CHO-S platform and their proprietary EMABling® platform. LFB Biotechnologies SASU is a subsidiary of LFB BIOMANUFACTURING, which is ultimately controlled by the Government of France. MAbgène was acquired by LFB Biotechnologies SASU on November 30, 2007 for $4.09 million. | Health Technology |
| Septimanie Export | |
| Mistral Investissements |
